Overview
The 2027 International Brain Stimulation conference will be the seventh edition of the largest international conference in brain stimulation.
The conference was started by Dr Harold Sackeim and Dr Mark George, who together also founded the Brain Stimulation journal. Dr Sackeim and Dr George co-chaired every past conference with compounding attendance and breakthrough science each edition.
For the 2027 conference, Dr Charlotte Stagg and Dr Marom Bikson will take on the roles of conference co-chairs. As deputy editors of Brain Stimulation and members of past edition conference program committee, Dr Stagg and Dr Bikson we approach this opportunity with great deference for the success built by Dr Sackeim and Dr George and the entire brain stimulation community, and with and aspirations for new vistas for the International Brain Stimulation conference.
The 2027 conference will showcase rapid breakthrough in brain stimulation technology, major clinical advances, and enhance opportunities for new ideas and investigators. The International Brain Stimulation exhibits remain the best place to experience the latest devices and software - and in 2027 we hope to include a new “Innovations Corner” to include early and pre-market technologies.
Faculty
Conference Co-Chairs
Local Organizing Committee
Conference Co-Founders
Program Committee
Plenary Speakers
Topics
- Deep Brain Stimulation (DBS)
- Electroconvulsive Therapy (ECT)
- Epidural Cortical Stimulation and Microstimulation
- Transcranial Ultrasound Stimulation (tUS) / Low Intensity Focused Ultrasound (LIFU)
- Pulsed Ultrasound (pUS)
- High Intensity Focused Ultrasound (HIFU)
- Transcranial Magnetic Stimulation (TMS)
- Transcranial Alternating Current Stimulation (tACS)
- Transcranial Direct Current Stimulation (tDCS)
- Transcranial Random Noise Stimulation (tRNS)
- Vagus Nerve Stimulation (VNS) and Cranial Nerve Stimulation
- Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS)
- Transcranial photobiomodulation (tPBM) and Light Based Neuromodulation
- Temporal Interference Stimulation
- Neuroprostheses / Functional Electrical Stimulation
- Focal Pharmacology
- Brain-computer Interfaces and bidirectional BCI
- Other Techniques
Experimental Models (Optional)
- Modeling and computational methods
- Cellular / in vitro Mechanisms of Stimulation
- Preclinical models
- Electroencephalography (EEG) / Magnetoencephalography (MEG)
- Electromyography (EMG)
- Functional Brain Imaging
- Structural Brain Imaging
- Hardware / Power / Electrode Design
- Neuronavigation
Purpose / Application (Optional)
- Focal Pharmacology
- Responsive (Closed-Loop) Stimulation
- Brain-computer Interfaces and bidirectional BCI
- Neuroprostheses
- Neurorehabilitation
- Neuropharmacology
- Neurophysiology
- Neuroplasticity
- Neuropsychology
Industry Sponsored Workshops
Registration for these industry sponsor workshops will open shortly. All dates are February 2027.
| DATE / TIME | SPONSOR | WORKSHOP / THEME |
|---|---|---|
| Sunday, 21 Feb 2027 10:00 a.m.–5:00 p.m. |
Soterix Medical |
Advanced Neuromodulation and Neuromonitoring Training Workshop with Updates on the Latest Technologies Fundamentals and advanced applications of neuromodulation and neuromonitoring, including tES/HD-tES, EEG, TI/IFS, rTMS, tFUS, GVS, taVNS and closed-loop tES. |
| Sunday, 21 Feb 2027 10:00 a.m.–1:00 p.m. |
MagVenture |
Education in MST — The Next Wave of Convulsive Therapy Scientific and clinical foundations, evidence and future potential of Magnetic Seizure Therapy (MST). Free session. |
| Sunday, 21 Feb 2027 2:00–5:00 p.m. |
MagVenture |
MST Early Pioneer Training & Technology Certification Hands-on training and certification for clinicians and researchers. Registration fee: €399. |
| Sunday, 21 Feb 2027 2:00–5:00 p.m. |
BRAINBOX | Workshop details to be announced. |
| Monday, 22 Feb 2027 7:30–8:30 a.m. |
MagVenture | Next-gen TMS Technology — Personalization, Accelerated, Precision-enabled TMS |
| Monday, 22 Feb 2027 7:30–8:30 a.m. |
Sigmastim |
ECT Barriers to Treatment: Why Is It Difficult for Most Patients to Access ECT? Discussion of barriers to ECT access in the USA, Canada, Australia and Ireland. Light breakfast included. |
| Monday, 22 Feb 2027 7:30–8:30 a.m. |
Vielight | Workshop details to be announced. |
| Tuesday, 23 Feb 2027 7:30–8:30 a.m. |
MagVenture | Future of Convulsive Therapy — MST (MagVenture NEURON™ Therapy) |
| Tuesday, 23 Feb 2027 7:30–8:30 a.m. |
LivaNova |
Implementing VNS Therapy for Difficult-to-Treat Depression in Clinical Practice — Practical Experience and Best Practice Patient selection, treatment pathways, long-term management and RECOVER trial data. |
| Wednesday, 24 Feb 2027 7:30–8:30 a.m. |
STORZ MEDICAL |
Transcranial Pulse Stimulation (TPS) for Non-Invasive Brain Stimulation: Latest Advances and Future Directions Latest developments in TPS and the NEUROLITH device. |
Program
Four days of plenary lectures, symposia, poster sessions and industry workshops. Parallel symposia are shown grouped by time slot; individual session titles are published as the scientific program is finalized. All times are local (CET) and subject to change.
Showing all 4 days of the program.
Sunday, 21 February 2027
| TIME | SESSION |
|---|---|
| 09:00–17:00 | Soterix Medical Workshop |
| 10:00–13:00 |
MagVenture Workshop — Next wave of convulsive therapy using MagVenture MST Technology Kevin A. Caulfield Morning session (free to attend): Education in MST — the next wave of convulsive therapy using Non-invasive Electromagnetic Ultra Rapid Onset Neuromodulation Therapy. |
| 13:00–17:00 | BrainBox Workshop |
| 14:00–17:00 |
MagVenture Workshop — Next wave of convulsive therapy using MagVenture MST Technology Kevin A. Caulfield Afternoon session (extra fee applicable): MST early pioneer training and technology certification with full demo and hands-on with the equipment. |
No sessions match your search on this day.
Monday, 22 February 2027
| TIME | SESSION |
|---|---|
| 07:00–09:00 | Registration |
| 07:30–08:30 | MagVenture Workshop: Next-gen TMS technology — personalization, accelerated, precision-enabled TMS |
| 07:30–08:30 | Vielight Workshop Presentation type: Oral |
| 07:30–09:00 | Symposia — 3 parallel sessions Presentation type: Oral |
| 09:15–09:30 | Opening Remarks |
| 09:30–10:15 | Plenary Lecture 1 [PL.01] Presentation type: Oral |
| 10:15–11:00 | Plenary Lecture 2 [PL.02] Presentation type: Oral |
| 11:00–11:30 | Refreshment break |
| 11:30–12:15 | Plenary Lecture 3: Hot Topic Lecture [PL.03] Presentation type: Oral |
| 12:15–12:30 | Presentation of the International Brain Stimulation Awards |
| 12:30–13:15 |
Plenary Lecture 4 [PL.04] Presentation given by the winner of the International Brain Stimulation Award. Presentation type: Oral |
| 13:15–14:15 | Lunch and Poster Session 1 Presentation type: Poster |
| 14:15–16:15 | Symposia — 6 parallel sessions Presentation type: Oral |
| 16:15–16:45 | Refreshment break |
| 16:45–18:45 | Symposia — 6 parallel sessions Presentation type: Oral |
| 19:00–20:00 |
Welcome Drinks Reception & Poster Session 1 (continued) Welcome reception kindly sponsored by LivaNova. Presentation type: Poster |
No sessions match your search on this day.
Tuesday, 23 February 2027
| TIME | SESSION |
|---|---|
| 07:00–09:00 | Symposia — 3 parallel sessions Presentation type: Oral |
| 07:30–08:30 |
LivaNova Workshop — Implementing VNS Therapy for Difficult to Treat Depression in clinical practice: consensus statements, practical experience and best practice This clinical workshop explores the practical implementation of implantable Vagus Nerve Stimulation (VNS) Therapy for patients with difficult to treat depression. Drawing on expert consensus statements, real world clinical experience and the latest data from the RECOVER randomised control trial, the session will address patient selection, treatment pathways and long term management. Best practice recommendations will be discussed, alongside case examples illustrating common challenges and solutions, to support clinicians in safely and effectively integrating VNS Therapy into routine clinical practice. Presentation type: Workshop |
| 07:30–08:30 | Magstim Workshop Presentation type: Workshop |
| 07:30–08:30 | MagVenture Workshop: Future of convulsive therapy — MST (MagVenture NEURON™ Therapy) Presentation type: Workshop |
| 09:15–10:00 | Plenary Lecture 5 [PL.05] Presentation type: Oral |
| 10:00–10:45 | Plenary Lecture 6 [PL.06] Presentation type: Oral |
| 10:45–11:15 | Refreshment break |
| 11:15–12:00 | Plenary Lecture 7 [PL.07] Presentation type: Oral |
| 12:00–12:45 |
Plenary Lecture 8 [PL.08] Presentation given by the winner of the Early Career Brain Stimulation Award. Presentation type: Oral |
| 12:45–13:45 | Lunch and Poster Session 2 Presentation type: Poster |
| 13:45–14:45 | Symposia — 6 parallel sessions Presentation type: Oral |
| 15:00–16:30 | Workshops Hands on demonstrations and round table discussions with experts. |
| 16:30–17:00 | Refreshment break |
| 17:00–18:00 | Symposia — 6 parallel sessions Presentation type: Oral |
| 18:00–19:00 | Poster Session 2 (continued) Presentation type: Poster |
| 20:00–23:00 |
Conference Dinner Conference dinner kindly sponsored by Sigmastim. Return coaches from the convention centre provided. |
No sessions match your search on this day.
Wednesday, 24 February 2027
| TIME | SESSION |
|---|---|
| 07:00–09:00 | Symposia — 3 parallel sessions Presentation type: Oral |
| 07:30–08:30 | Editorial Board meeting (closed meeting — by invitation only) |
| 07:30–08:30 |
Storz Medical Workshop — Transcranial Pulse Stimulation (TPS) for Non-Invasive Brain Stimulation: Latest Advances and Future Directions Transcranial Pulse Stimulation (TPS) is an innovative treatment for patients with Alzheimer’s dementia, utilizing low-energy acoustic pulse waves to target affected brain regions. The NEUROLITH device, CE-approved since 2018, is designed for TPS treatment and delivers energy non-invasively, reaching depths of up to 8 centimetres. A standard TPS treatment protocol involves six sessions within two weeks, with each session lasting approximately 30 minutes. Follow-up sessions are tailored individually, typically scheduled 4 to 8 weeks after the initial treatment series. The TPS application is visually monitored, enabling real-time tracking of targeted brain areas, ensuring accuracy and safety. Clinical studies have shown significant cognitive improvements in patients with Alzheimer’s dementia undergoing TPS therapy, and ongoing research is exploring broader therapeutic applications of TPS for various neurological conditions. Participants will gain insights into TPS technology, current research developments, and practical applications in the treatment of patients with Alzheimer’s disease and beyond. Presentation type: Workshop |
| 07:30–08:30 | Industry Workshops Presentation type: Workshop |
| 09:15–10:00 | Plenary Lecture 9: Hot Topic Lecture 2 [PL.09] Presentation type: Oral |
| 10:00–11:00 | Symposia — 6 parallel sessions Presentation type: Oral |
| 11:00–11:30 | Refreshment break |
| 11:30–12:30 | Symposia — 6 parallel sessions Presentation type: Oral |
| 12:30–13:30 | Lunch and Poster Session 3 Presentation type: Poster |
| 13:30–15:30 | Symposia — 6 parallel sessions Presentation type: Oral |
| 15:30–16:00 | Refreshment break |
| 16:00–17:00 | Symposia — 6 parallel sessions Presentation type: Oral |
| 17:00–18:00 | Poster Session 3 (continued) Presentation type: Poster |
| 18:00–18:15 | Closing remarks & awards |
No sessions match your search on this day.
Venue
Lyon Convention Centre (Palais des congrès de Lyon)
50 Quai Charles de Gaulle, 69006 Lyon, France
Register
Reserve your spot for the 7th International Brain Stimulation Conference.
Date
February 21 – 24, 2027
Location
Lyon Convention Centre
50 Quai Charles de Gaulle
69006 Lyon, France